Trial intelligence / Profile preview

Comparison of Ropivacaine + Lignocaine versus Bupivacaine + Lignocaine for Medial Canthal Block in Cataract Surgery

TCTR20260417005Phase 2Not yet recruiting

Sponsor
Mantish Kumar
Start
Apr 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ropivacaine, bupivacaine, lidocaine in cataract, sponsored by Mantish Kumar. Planned start Apr 2026; status: not yet recruiting.

02

Drugs

ropivacainebupivacainelidocaine
03

Conditions

cataract

Beyond the preview

Go deeper on TCTR20260417005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260417005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call